Abstract
Purpose of the study: To estimate the prevalence of HIV 1 and HIV 2 infection in patients attending the tertiary care setup. Routine screening for HIV infection of 10000 samples were carried out between July 2017-June 2018. All patients were given a pre-test counselling and filled up the Consent form provided by NACO. The samples were subjected to the NACO provided Comb Aids RS Advantage kit and all positives were tested using 2 other kits Meriscreen HIV 1-2 and Tridot Test for differentiation. The data thus obtained were charted in Excel and the prevalence were determined. A Post-test counselling was given for all patients and the results were disclosed following the protocol provided by NACO. Of the 10000 samples, 82 (0.82%) samples were reactive for HIV. In the 82 reactive samples, 78 (95.12%) samples were reactive for HIV- 1 antibodies and 4 (4.8%) samples were reactive for HIV-2 antibodies. Among the 82 reactive clients, 53 clients were male and 29 clients were female.
Publisher
Journal of Pure and Applied Microbiology
Subject
Applied Microbiology and Biotechnology,Microbiology,Biotechnology
Reference9 articles.
1. 1. AIDS by the numbers-Factsheet. 2015. UNAIDS. USA.
2. 2. Simoes EA, Babu PG, John TJ, et al. Evidence for HTLV-III infection in prostitutes in Tamil Nadu (India). Indian J Med Res. 1987;85:335-338.
3. 3. Rubsamen-Waigmann H, Briesen HV, Maniar JK, Rao PK, Scholz C, Pfutzner A. Spread of HIV-2 in India. Lancet 1991;337(8740): 550-551. doi: 10.1016/0140-6736(91)91333-P
4. 4. Leano PS, Kageyama S, Espantaleon A, et al. Introduction of human immunodeficiency virus type 2 infection in the Philippines. J Clin Microbiol. 2003;41(1):516-518 doi: 10.1128/JCM.41.1.516-518.2003
5. 5. Tadokar VS, Kavathekar MS. Seroprevalence of human immunodefciency virus type 2 infection from a tertiary care hospital in Pune, Maharashtra: A 2 year study. Indian J Med Microbiol. 2013;31(3):314-315. doi: 10.4103/0255-0857.115670